GL1X · GenesisL1 explorer

MolNFT v1 · #189473 · protein

Crystal structure of SARS-cov-2 main protease in complex with protease inhibitor pf-07321332

7VH8 · 3C-like proteinase: “Crystal structure of SARS-cov-2 main protease in complex with protease inhibitor pf-07321332”. X-ray diffraction, 2 ligands (4WI, H2S), 2 pockets (best druggability 0.51). MolNFT v1 #189473 on GenesisL1: 3D…

PDB
7VH8
Type
protein
Length
306 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTC1
Ligands
4WI, H2S
Pockets
2 · best druggability 0.51

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30626% helix, 29% strandP0DTC1

Ligands and binding sites

  • 4WI · (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide · ligand · chains A
  • H2S · Hydrosulfuric acid · ion · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12020.510.77254WI
21680.460.7527empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7VH8 · Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.